InvestorsHub Logo

_SuperPennies_

11/20/20 1:20 AM

#38782 RE: Clemdane #37911

Share Holders Update


BLULLISH

12/01/20 5:13 AM

#39054 RE: Clemdane #37911

SHMN has produces 300 Generic Drugs

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158115031

The Company’s strategic manufacturing facility enables low production costs without compromising quality. SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution.